These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 1260201)

  • 1. Proceedings: Is metoclopramide a directly acting dopamine receptor antagonist?
    Donaldson IM; Jenner P; Marsden CD; Miller R; Peringer E
    Br J Pharmacol; 1976 Mar; 56(3):373P. PubMed ID: 1260201
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure activity studies on dopamine receptors; a comparison between rat striatal adenylate cyclase and Helix aspersa neurones [proceedings].
    Munday KA; Poat JA; Woodruff GN
    Br J Pharmacol; 1976 Jul; 57(3):452P-453P. PubMed ID: 974347
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of functional dependence on ethanol in dopaminergic systems.
    Tabakoff B; Hoffman PL
    J Pharmacol Exp Ther; 1979 Feb; 208(2):216-22. PubMed ID: 570225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metoclopramide and dopamine receptor blockade.
    Miller R
    Neuropharmacology; 1976 Aug; 15(8):463-9. PubMed ID: 980223
    [No Abstract]   [Full Text] [Related]  

  • 5. [Proceedings: Dopamine receptor and antipsychotic effects (author's transl)].
    Karobath M
    Arzneimittelforschung; 1976; 26(6):1029-30. PubMed ID: 9103
    [No Abstract]   [Full Text] [Related]  

  • 6. Adenosine-sensitive adenylate cyclase in rat striatal homogenates and its relationship to dopamine- and Ca2+-sensitive adenylate cyclases.
    Prémont J; Perez M; Bockaert J
    Mol Pharmacol; 1977 Jul; 13(4):662-70. PubMed ID: 887074
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative dopamine-cholinergic mechanisms in the olfactory tubercle and the striatum: effects of metoclopramide.
    Suarez-Roca H; Lovenberg T; Cubeddu LX
    J Pharmacol Exp Ther; 1987 Dec; 243(3):840-51. PubMed ID: 3320346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of chlorpromazine on dopaminergic receptor functions in rat brain--difference of the response of several dopaminergic systems after chronic administration (author's transl)].
    Kaneno S
    Seishin Shinkeigaku Zasshi; 1980 Jun; 82(6):335-52. PubMed ID: 7465695
    [No Abstract]   [Full Text] [Related]  

  • 9. Is adenylate cyclase the dopamine receptor?
    Arbuthnott GW; Attree TJ; Eccleston D; Loose RW; Martin MJ
    Med Biol; 1974 Oct; 52(5):350-3. PubMed ID: 4372496
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in mesolimbic homovanillic acid content following discrete modulation of striatal dopamine systems [proceedings].
    Costall B; Naylor RJ
    Br J Pharmacol; 1979 May; 66(1):105P-106P. PubMed ID: 454900
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Behavioural and biochemical evidence for cerebral dopamine receptor blockade by metoclopramide in rodents.
    Jenner P; Marsden CD; Peringer E
    Br J Pharmacol; 1975 Jun; 54(2):275P-276P. PubMed ID: 1148554
    [No Abstract]   [Full Text] [Related]  

  • 12. Endogenous guanyl nucleotides: components of the striatum which confer dopamine-sensitivity to adenylate cyclase.
    Kebabian JW; Chen TC; Cote TE
    Commun Psychopharmacol; 1979; 3(6):421-8. PubMed ID: 546590
    [No Abstract]   [Full Text] [Related]  

  • 13. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
    Heijna MH; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
    J Pharmacol Exp Ther; 1989 Jun; 249(3):864-8. PubMed ID: 2543814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of drugs on metoclopramide-induced catalepsy and increase in striatal homovanillic acid content.
    Ahtee L
    Br J Pharmacol; 1975 Mar; 53(3):460P. PubMed ID: 1169083
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective influence of ergot alkaloids on cortical and striatal dopaminergic and sergotonergic receptors.
    Rosenfeld MR; Makman MH; Ahn HS; Thal LJ; Mishra RK; Katzman R
    Adv Biochem Psychopharmacol; 1980; 23():83-93. PubMed ID: 6249092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of (-)deprenyl, 1-phenyl-2-propyl-aminopentane (MK-306) and amphetamine on the striatal and limbic dopaminergic system.
    Timár J; Yasar S; Knoll B; Knoll J
    Acta Physiol Hung; 1990; 75 Suppl():279-80. PubMed ID: 2115233
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Noradrenaline-sensitive adenylate cyclase in rat limbic forebrain homogenates: effects of agonists and antagonists.
    Horn AS; Phillipson OT
    Br J Pharmacol; 1975 Oct; 55(2):299P-300P. PubMed ID: 172179
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: Action of LSD on supersensitive mesolimbic dopamine receptors.
    Kelly PH
    Br J Pharmacol; 1975 Oct; 55(2):291P. PubMed ID: 1201419
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relative role of dopamine and norepinephrine receptor blockade in the action of antipsychotic drugs: metoclopramide, thiethylperazine, and molindone as pharmacological tools.
    Robinson SE; Berney S; Mishra R; Sulser F
    Psychopharmacology (Berl); 1979 Aug; 64(2):141-7. PubMed ID: 40288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.